IBEX 35
11.032,30 -128,20 (-1,15%) Euro Stoxx 50
4.907,30 -40,43 (-0,82%) Dólar/Euro
1,0692 -0,0015 (-0,14%) Petróleo Brent
85,07 -0,17 (-0,20%) Oro
2.334,70 +3,50 (+0,15%) Bitcoin EUR
59.965,77 -139,59 (-0,23%)
Jolt Health Inc. (JOLT.CN)
Jolt Health Inc.
1780 -355 Burrard Street
Vancouver, BC V6C 2G8
Canada
604-343-2977
https://jolt-health.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Descripción
Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada, the Netherlands, rest of Europe, and Jamaica. The company focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses. It offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for a variety of conditions. The company also provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel. The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023. Jolt Health Inc. is headquartered in Vancouver, Canada.
Gobierno corporativo
El ISS Governance QualityScore de Jolt Health Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
